AICIS completed an evaluation of HCB under Part 4 of the Industrial Chemicals 2019 Act. AICIS published its final evaluation statement on 22 December 2022 following public consultation.
An obligation to provide specific information to AICIS will be added to the terms of listing for musk tibetene and a structural analogue on the Australian Inventory of Industrial Chemicals (Inventory).
AICIS completed an evaluation of PeCB under Part 4 of the Industrial Chemicals 2019 Act. AICIS published its final evaluation statement on 22 December 2022 following public consultation.
The Executive Director has varied the terms of the Inventory listing for several chemicals because approval was revoked for the proper name of the industrial chemicals to be treated as confidential business information (CBI).